Cover Image

Incidencia de neutropenia febril en pacientes pediátricos con diagnósticos hemato-oncológicos del Hospital Civil de Guadalajara "Dr. Juan I. Menchaca"

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Authors:	Salceda Rivera, Violeta, Gallegos Castorena, Sergio, Medina Escobar, Rina Alejandra
Format:	Recurso digital
Language:	Spanish
Published:	Zenodo 2025
Subjects:	Hematology Medical Oncology Febrile Neutropenia Child
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Febrile neutropenia management in pediatric onco-hematologic patients: a systematic review
by: Tatiane Berte
Published: (2021)

Piperacilina/tazobactam más amikacina vs. piperacilina/tazobactam: tratamiento en niños con neutropenia febril
by: Daniel Octavio Pacheco-Rosas
Published: (2019)

Clinical and Biochemical diagnosis of patients with febrile neutropenia attended Babylon Cancer Treatment center
by: Mushtaq Qahtan Ali
Published: (2021)

Bacteriemia asociada a neutropenia febril en pacientes hemato-oncológicos, su espectro bacteriano y patrón de susceptibilidad antibiótica
by: Lucy Johanna Hinojosa-Andía
Published: (2014)

Microbiological diagnosis in febrile neutropenia secondary to chemotherapy for hematologicmalignancy. A cohort description
by: Karen Andrea García-Rueda
Published: (2020)

Neutropenia febril en pacientes pediátricos: un enfoque diagnóstico y terapéutico
by: Carolina Jaramillo Arango
Published: (2009)

La neutropenia severa febril en niños con cáncer. Estudio descriptivo en el Hospital Universitario de Santander
by: Ernesto Rueda
Published: (2010)

Características de los pacientes adultos con neutropenia febril en un hospital universitario (Medellín, 2012-2016)
by: Tatiana Arroyave-Peña
Published: (2019)

Crecimiento in vitro y morfología inusual de Campylobacter aislada de un paciente con bacteriemia
by: Jesús Rojas-Jaimes
Published: (2019)

Estado actual del manejo de la fiebre en niños
by: Fabián Alberto Rueda Zambrano
Published: (2010)

Evaluación del desenlace y características clínicas de una serie de niños con neutropenia febril sin foco en el Hospital Universitario San Vicente de Paúl, Medellín, Colombia, 2000-2005
by: Carolina Jaramillo Arango
Published: (2008)

Perfil clínico y microbiológico de niños con neutropenia febril posterior a tratamientos antineoplásicos tratados en una institución hospitalaria de Medellín (Colombia), 2009-2010: Estudio de serie de casos
by: María Juliana Palacio Mesa
Published: (2015)

Análisis descriptivo de los motivos que originan visitas a urgencias en pacientes oncológicos: toxicidad postquimioterapia
by: Silvia Buendía Bravo
Published: (2015)

Clozapina, neutropenia y test de prednisona
by: Cristian Wulff M.
Published: (2007)

Hospital Palliative Care Team Consultations in Different Subgroups of Hematologic Malignancies
by: Anja M. Caspers, et al.
Published: (2024)

Lactato sérico como biomarcador de sepsis grave en niños con cáncer, neutropenia y fiebre
by: Daniel Octavio Pacheco-Rosas
Published: (2014)

El virus HHV-6 y su relación con los trastornos del neurodesarrollo.
by: Alma Dzib Goodin
Published: (2012)

Febrile neutropenia in the tropics: A description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia
by: Jorge A. Cortés
Published: (2013)

730 | RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY OF PEMBOLIZUMAB BIOSIMILAR BCD‐201 IN PATIENTS WITH REFRACTORY CLASSICAL HODGKIN’S LYMPHOMA
by: E. A. Gracia Medina, et al.
Published: (2025)

257 | ZANUBRUTINIB IN RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL): EFFICACY AND SAFETY OF 101 SPANISH PATIENTS TREATED IN THE REAL‐WORLD ON BEHALF OF GELTAMO
by: F. Martin‐Moro, et al.
Published: (2025)

Caracterización de pacientes pediátricos con neutropenia enviados a un hospital de referencia
by: Gustavo Adolfo Lazo-Páez
Published: (2010)

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell Lymphoma
by: Juliette Penichoux, et al.
Published: (2025)

Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis
by: Maria Livia Del Giudice, et al.
Published: (2024)

Upregulated miR‐29a‐3p Prevent Malignant Features of Lymphoma Cells by Targeting MCL1
by: Tengfei Shi, et al.
Published: (2025)

Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma
by: Akihiko Izumi, et al.
Published: (2025)

Identifying Clones in Myelodysplastic Syndromes by Using Single‐Cell RNA Sequencing
by: Roy Pollak, et al.
Published: (2026)

444 | A PHASE 1 STUDY OF SGR‐1505, AN ORAL, POTENT MALT1 INHIBITOR FOR R/R B‐CELL MALIGNANCIES, INCLUDING CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
by: V. Musteata, et al.
Published: (2025)

72 | SEQUOIA 5‐YEAR FOLLOW‐UP IN ARM C: FRONTLINE ZANUBRUTINIB IN PATIENTS WITH DEL(17P) AND TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
by: C. S. Tam, et al.
Published: (2025)

In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T‐Cell Neoplasms
by: Marie Therese Manipadam, et al.
Published: (2024)

Comparative Safety of Ibrutinib Versus Zanubrutinib in Patients With Chronic Lymphocytic Leukemia: A Prospective Cohort Study
by: Fuli Fan, et al.
Published: (2025)

Exploratory Analysis of Practical Predictive Indices for the Efficacy of Mogamulizumab in Patients With Aggressive Adult T‐Cell Leukemia‐Lymphoma
by: Yutaka Shimazu, et al.
Published: (2025)

Clonal dynamics of Richter transformation in chronic lymphocytic leukemia
by: Hanyin Wang, et al.
Published: (2024)

598 | REDEFINING CLASSIFICATION ALGORITHM AND STAGING SYSTEM IN MARGINAL ZONE LYMPHOMA
by: C. Bommier, et al.
Published: (2025)

Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study
by: Dong Liang, et al.
Published: (2025)

Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients
by: A. Zduniak, et al.
Published: (2024)

Autoimmune Complications of Lymphoproliferative Diseases
by: Wilma Barcellini, et al.
Published: (2025)

Current Status of Revisions to the Lugano Classification in Lymphoma
Published: (2025)

The role of baseline 2‐[ 18 F]‐FDG‐PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis
by: Domenico Albano, et al.
Published: (2024)

Long‐Term Follow‐Up of Chidamide With Chemotherapy in Untreated Peripheral T‐Cell Lymphoma: One Single Center Real‐World Study in China
by: Jiajie He, et al.
Published: (2026)

Issue Information
Published: (2026)